A detailed history of Dark Forest Capital Management LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 100,280 shares of ABCL stock, worth $296,828. This represents 0.08% of its overall portfolio holdings.

Number of Shares
100,280
Previous 10,490 855.96%
Holding current value
$296,828
Previous $59,000 669.49%
% of portfolio
0.08%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.29 - $5.97 $385,199 - $536,046
89,790 Added 855.96%
100,280 $454,000
Q4 2023

Feb 14, 2024

SELL
$3.91 - $5.93 $1.05 Million - $1.59 Million
-268,128 Reduced 96.23%
10,490 $59,000
Q3 2023

Nov 13, 2023

BUY
$4.6 - $7.95 $853,787 - $1.48 Million
185,606 Added 199.55%
278,618 $1.28 Million
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $440,472 - $590,668
77,822 Added 512.32%
93,012 $600,000
Q1 2023

May 12, 2023

BUY
$7.31 - $11.18 $99,978 - $152,908
13,677 Added 903.97%
15,190 $114,000
Q4 2022

Feb 13, 2023

BUY
$9.48 - $14.52 $11,650 - $17,845
1,229 Added 432.75%
1,513 $15,000
Q3 2022

Nov 14, 2022

SELL
$9.2 - $13.68 $18,262 - $27,154
-1,985 Reduced 87.48%
284 $3,000
Q2 2022

Aug 15, 2022

SELL
$5.72 - $10.65 $50,387 - $93,815
-8,809 Reduced 79.52%
2,269 $24,000
Q1 2022

May 13, 2022

BUY
$7.46 - $14.14 $58,889 - $111,621
7,894 Added 247.93%
11,078 $108,000
Q4 2021

Feb 11, 2022

BUY
$12.99 - $17.73 $41,360 - $56,452
3,184 New
3,184 $46,000
Q3 2021

Nov 12, 2021

SELL
$14.85 - $21.34 $2,331 - $3,350
-157 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $3,169 - $5,364
157 New
157 $3,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $844M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.